Cholangiolocarcinoma With Multiple Recurrences Successfully Treated With Repeated Liver Resection and Radiofrequency Ablation.


Journal

Anticancer research
ISSN: 1791-7530
Titre abrégé: Anticancer Res
Pays: Greece
ID NLM: 8102988

Informations de publication

Date de publication:
Dec 2020
Historique:
received: 03 11 2020
revised: 12 11 2020
accepted: 13 11 2020
entrez: 8 12 2020
pubmed: 9 12 2020
medline: 18 12 2020
Statut: ppublish

Résumé

The prognosis of cholangiolocarcinoma, a rare malignant liver tumor derived from hepatic progenitor or stem cells, is considered relatively good; however, it frequently recurs. We herein present the diagnosis, histological findings, and treatment of cholangiolocarcinoma. A 65-year-old woman with a large liver tumor (70 mm in diameter) was referred. Hepatocellular carcinoma was suspected based on strong early enhancement and delayed washout by enhanced computed tomography. The patient underwent curative left tri-sectionectomy. Histologically, she was diagnosed with pure cholangiolocarcinoma in a slightly fibrous liver. Three metachronous recurrent lesions (all ≤10 mm in diameter) were found between fifteen and twenty months after the initial hepatectomy. One lesion and the remaining two lesions were treated with hepatectomy and radiofrequency ablation, respectively. Two years after the initial diagnosis, she was doing well without recurrence. Repeated hepatectomy and radiofrequency ablation might be useful for small intrahepatic recurrences of cholangiolocarcinoma.

Sections du résumé

BACKGROUND/AIM OBJECTIVE
The prognosis of cholangiolocarcinoma, a rare malignant liver tumor derived from hepatic progenitor or stem cells, is considered relatively good; however, it frequently recurs. We herein present the diagnosis, histological findings, and treatment of cholangiolocarcinoma.
CASE REPORT METHODS
A 65-year-old woman with a large liver tumor (70 mm in diameter) was referred. Hepatocellular carcinoma was suspected based on strong early enhancement and delayed washout by enhanced computed tomography. The patient underwent curative left tri-sectionectomy. Histologically, she was diagnosed with pure cholangiolocarcinoma in a slightly fibrous liver. Three metachronous recurrent lesions (all ≤10 mm in diameter) were found between fifteen and twenty months after the initial hepatectomy. One lesion and the remaining two lesions were treated with hepatectomy and radiofrequency ablation, respectively. Two years after the initial diagnosis, she was doing well without recurrence.
CONCLUSION CONCLUSIONS
Repeated hepatectomy and radiofrequency ablation might be useful for small intrahepatic recurrences of cholangiolocarcinoma.

Identifiants

pubmed: 33288615
pii: 40/12/7147
doi: 10.21873/anticanres.14745
doi:

Types de publication

Case Reports Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

7147-7153

Informations de copyright

Copyright © 2020 International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved.

Auteurs

Nobutaka Sato (N)

Department of Surgery, Yamaga City Medical Center, Kumamoto, Japan.

Kensuke Yamamura (K)

Department of Surgery, Yamaga City Medical Center, Kumamoto, Japan.

Eri Oda (E)

Department of Surgery, Yamaga City Medical Center, Kumamoto, Japan.

Shinichi Akahoshi (S)

Department of Surgery, Yamaga City Medical Center, Kumamoto, Japan.

Hideaki Yuki (H)

Department of Radiology, Yamaga City Medical Center, Kumamoto, Japan.

Toshihiko Motohara (T)

Department of Gastroenterology, Yamaga City Medical Center, Kumamoto, Japan.

Hideaki Miyamoto (H)

Department of Medical Oncology, Yamaga City Medical Center, Kumamoto, Japan.

Daiki Yoshii (D)

Department of Cell Pathology, Graduate School of Medicine, Kumamoto University, Kumamoto, Japan.

Yoshihiko Komohara (Y)

Department of Cell Pathology, Graduate School of Medicine, Kumamoto University, Kumamoto, Japan.

Toru Beppu (T)

Department of Surgery, Yamaga City Medical Center, Kumamoto, Japan tbeppu@yamaga-mc.jp.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH